Icecure Medical Ltd
ICCM0.590USD
+0.039+7.04%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
40.69M시가총액
손실P/E TTM
자세한 내용은 Icecure Medical Ltd 회사
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
Icecure Medical Ltd 정보
종목 코드 ICCM
회사 이름Icecure Medical Ltd
상장일Feb 02, 2011
CEOShamir (Eyal)
직원 수64
유형Ordinary Share
회계 연도 종료Feb 02
주소7 Ha'eshel St.
도시CAESAREA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Israel
우편 번호3079504
전화97246230333
웹사이트https://icecure-medical.com/
종목 코드 ICCM
상장일Feb 02, 2011
CEOShamir (Eyal)
Icecure Medical Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Eyal Shamir
Mr. Eyal Shamir
Chief Executive Officer, Director
Chief Executive Officer, Director
590.31K
+69673.00%
Mr. Ronen Tsimerman
Mr. Ronen Tsimerman
Vice President - Finance, Vice President - Operations
Vice President - Finance, Vice President - Operations
355.08K
+47555.00%
Mr. Naum Muchnik
Mr. Naum Muchnik
Vice President - Research & Development
Vice President - Research & Development
140.42K
+35127.00%
Mr. Oded Tamir
Mr. Oded Tamir
External Director
External Director
20.00K
+10000.00%
Ms. Elisabeth Sadka
Ms. Elisabeth Sadka
Vice President-Clinics, Regulations and Quality Assurance
Vice President-Clinics, Regulations and Quality Assurance
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
External Director
External Director
--
--
Mr. Doron Birger
Mr. Doron Birger
Independent Director
Independent Director
--
--
Mr. Ron Abraham Mayron
Mr. Ron Abraham Mayron
Chairman of the Board
Chairman of the Board
--
--
Ms. Tlalit Bussi Tel-Tzure
Ms. Tlalit Bussi Tel-Tzure
Vice President - Business Development & Marketing
Vice President - Business Development & Marketing
--
--
Ms. Sharon Levita
Ms. Sharon Levita
External Director
External Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Eyal Shamir
Mr. Eyal Shamir
Chief Executive Officer, Director
Chief Executive Officer, Director
590.31K
+69673.00%
Mr. Ronen Tsimerman
Mr. Ronen Tsimerman
Vice President - Finance, Vice President - Operations
Vice President - Finance, Vice President - Operations
355.08K
+47555.00%
Mr. Naum Muchnik
Mr. Naum Muchnik
Vice President - Research & Development
Vice President - Research & Development
140.42K
+35127.00%
Mr. Oded Tamir
Mr. Oded Tamir
External Director
External Director
20.00K
+10000.00%
Ms. Elisabeth Sadka
Ms. Elisabeth Sadka
Vice President-Clinics, Regulations and Quality Assurance
Vice President-Clinics, Regulations and Quality Assurance
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
External Director
External Director
--
--
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
Other
1.46M
44.24%
United States
870.00K
26.44%
Japan
481.00K
14.62%
India
413.00K
12.55%
China
41.00K
1.25%
Israel
30.00K
0.91%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sat, Jan 31
마지막 업데이트: Sat, Jan 31
주주
주주 유형
주주
주주
비율
Haixiang (Li)
37.48%
Shamir (Eyal)
0.86%
Tsimerman (Ronen)
0.51%
Mayron (Ron)
0.40%
Tel-Tzure (Tlalit Bussi)
0.28%
기타
60.47%
주주
주주
비율
Haixiang (Li)
37.48%
Shamir (Eyal)
0.86%
Tsimerman (Ronen)
0.51%
Mayron (Ron)
0.40%
Tel-Tzure (Tlalit Bussi)
0.28%
기타
60.47%
주주 유형
주주
비율
Individual Investor
40.42%
Investment Advisor
0.39%
Hedge Fund
0.13%
Investment Advisor/Hedge Fund
0.06%
Research Firm
0.02%
Bank and Trust
0.02%
Venture Capital
0.02%
기타
58.94%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
31
443.26K
0.64%
+86.28K
2025Q3
33
241.02K
0.35%
-53.58K
2025Q2
45
28.04M
40.84%
+56.20K
2025Q1
44
28.01M
47.78%
-9.18K
2024Q4
41
27.61M
48.82%
+489.62K
2024Q3
42
27.95M
49.54%
-2.17M
2024Q2
41
27.48M
56.81%
+3.00M
2024Q1
39
27.22M
56.29%
+2.63M
2023Q4
40
21.73M
47.63%
-6.82M
2023Q3
37
21.68M
47.52%
-6.84M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Haixiang (Li)
25.85M
37.48%
--
--
Dec 31, 2024
Shamir (Eyal)
590.31K
0.86%
+69.67K
+13.38%
Mar 24, 2025
Tsimerman (Ronen)
355.08K
0.51%
+47.55K
+15.46%
Mar 24, 2025
Mayron (Ron)
278.02K
0.4%
+55.45K
+24.91%
Mar 24, 2025
Tel-Tzure (Tlalit Bussi)
191.81K
0.28%
+35.32K
+22.57%
Mar 24, 2025
Levav (Shay)
141.86K
0.21%
+37.69K
+36.18%
Mar 24, 2025
Muchnik (Naum)
140.42K
0.2%
+35.13K
+33.36%
Mar 24, 2025
Huang (Yang)
113.44K
0.16%
+40.12K
+54.72%
Mar 24, 2025
Dotan (Merav Nir)
88.94K
0.13%
+30.84K
+53.09%
Mar 24, 2025
Malik (Galit)
79.67K
0.12%
+23.32K
+41.40%
Mar 24, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
